Integrin α2β1-Targeted Self-Assembled Nanocarriers for Tumor Bioimaging-Reference-Cited by-同舟云学术

Integrin α2β1-Targeted Self-Assembled Nanocarriers for Tumor Bioimaging

Published:2020-07-27 Issue:9 Volume:3 Page:6059-6070
ISSN:2576-6422
Container-title:ACS Applied Bio Materials
language:en
Short-container-title:ACS Appl. Bio Mater.

Author:

Fluksman Arnon¹^ORCID,Steinberg Eliana¹,Orehov Natalie¹,Shai Ela²,Lahiani Adi¹,Katzhendler Jehoshua¹,Marcinkiewicz Cezary³,Lazarovici Philip¹,Benny Ofra¹^ORCID

Affiliation:

1. Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91121, Israel

2. Department of Hematology, Coagulation Unit, Hadassah−Hebrew University Medical Center, Jerusalem 91121, Israel

3. Department of Biology, Temple University College of Science and Technology, Philadelphia, Pennsylvania 19122, United States

Funder

Adolph and Klara Berettler Medical Research Center, Hebrew University of Jerusalem

David R. Bloom Center for Pharmacy, Hebrew University of Jerusalem

Alex Grass Center for Drug Design and Synthesis of Novel Therapeutics, Hebrew University of Jerusalem

Publisher

American Chemical Society (ACS)

Subject

Biochemistry, medical,Biomedical Engineering,General Chemistry,Biomaterials

Link

https://pubs.acs.org/doi/pdf/10.1021/acsabm.0c00662

Reference70 articles.

1. Advances and perspectives in near‐infrared fluorescent organic probes for surgical oncology

2. A review of NIR dyes in cancer targeting and imaging

3. Near infra-red polymeric nanoparticle based optical imaging in Cancer diagnosis

4. Near Infrared Receptor-Targeted Nanoprobes for Early Diagnosis of Cancers

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure–Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities;Pharmaceuticals;2024-04-24

2. ‘Passive’ nanoparticles for organ-selective systemic delivery: design, mechanism and perspective;Chemical Society Reviews;2023

3. Tumor-specific imaging probes in preclinical applications and clinical trials;Targeted Cancer Imaging;2022